SGRX — SANGRIX INC.

Is SGRX overbought or oversold? Here is the current MarketMoodz read.

Technology · Information Technology Services

Strong Oversold As of November 17, 2026

SANGRIX INC. (SGRX) currently reads Strong Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Technology name (Information Technology Services) last closed at $2.77. The rating moved from Oversold to Strong Oversold on November 16, 2026.

See all oversold Technology stocks →

AI analysis

SANGRIX INC. (SGRX) presents a limited-information, higher-risk microcap profile. Public disclosures and formal filings are not available for comparison, so core metrics such as revenue, cash runway, and debt are unknown. The stock’s low price and likely thin liquidity raise execution and volatility risks; small flows or headlines could move the quote materially. Broader market tone (cautious optimism/risk-on) may provide occasional short-term support, but sector-level regulatory and financing headwinds for tech vendors increase downside scenarios. Key catalysts would be credible, timely financial disclosure, evidence of sustainable revenue growth or a definitive financing that reduces near-term dilution risk, or material corporate developments (partnerships, contracts, M&A). Absent clearer financials or visible institutional support, the most likely near-term outcomes are sideways trading with episodic spikes or a downward move if financing/dilution pressure materializes.

Key factors

  • Limited/no recent public financial disclosures (no EDGAR comparison available) creates material information gap
  • Microcap/penny-stock profile with current price near $2.77 implies low liquidity and higher volatility
  • Market risk-on tone could provide short-term support for speculative small-cap names
  • Sector-level headwinds (regulatory scrutiny, capex uncertainty in tech/AI hardware) create a mixed backdrop for tech-related microcaps
  • Potential need for external financing implies dilution risk if cash runway is short
  • Absence of clear institutional ownership or social/research coverage increases idiosyncratic execution risk

Risks

  • Lack of transparent, recent audited filings — impaired ability to assess financial health and cash runway
  • Severe illiquidity and wide bid-ask spreads causing outsized price moves on limited flows
  • High dilution risk from equity raises or convertible financings
  • Operational/management execution uncertainty or possible undisclosed liabilities
  • Regulatory or sector shocks (export controls, procurement/regulatory scrutiny) that can disproportionately affect small vendors
  • Risk of trading suspension, delisting, or OTC-tier issues if reporting is not maintained

See today's live rating, score and targets

Members see the live hourly rating for SGRX — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.